PRKAA1 and neoplasm: Research reveals that in the tumor tissue of CRLM patients, AMPKα1 expression is significantly reduced, while the phosphorylation levels of mTORC1 downstream effectors are elevated, and this is correlated with an unfavorable prognosis (93).